Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBCUTANEOUSStandard

TERIPARATIDE

TERIPARATIDE

Standard Dose
0.56MG/2.24ML (0.25MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TERIPARATIDE is listed in Drugs@FDA under application 218771 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TERIPARATIDE Form and strength SOLUTION;SUBCUTANEOUS - 0.56MG/2.24ML (0.25MG/ML) Sponsor ALMAJECT Submission history Latest submission status date: 2025-01-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview TERIPARATIDE is listed in Drugs@FDA under application 218771 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TERIPARATIDE Form and strength SOLUTION;SUBCUTANEOUS - 0.56MG/2.24ML (0.25MG/ML) Sponsor ALMAJECT Submission history Latest submission status date: 2025-01-23 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.